| Name | Exarafenib |
|---|---|
| Synonyms |
(S)-N-(3-(2-(((R)-1-Hydroxypropan-2-yl)amino)-6-morpholinopyridin-4-yl)-4-methylphenyl)-3-(2,2,2-trifluoroethyl)pyrrolidine-1-cboxamide
1-Pyrrolidinecboxamide, N-[3-[2-[[(1R)-2-hydroxy-1-methylethyl]amino]-6-(4-morpholinyl)-4-pyridinyl]-4-methylphenyl]-3-(2,2,2-trifluoroethyl)-, (3S) exafenib |
| Description | Exarafenib (RAF/KIN_2787) is a potent, orally active pan-RAF inhibitor. Exarafenib has anticancer activity by suppression of downstream MAPK pathway signaling. Exarafenib can be used for cancer research[1][2]. |
|---|---|
| Related Catalog | |
| References |
[2]. WHO Drug Information. International Nonproprietary Names for Pharmaceutical |
| Molecular Formula | C26H34F3N5O3 |
|---|---|
| Molecular Weight | 521.58 |